[27P01-054S] Development of novel IL-6R/IL-6 interaction inhibitors for severe COVID-19 pneumonia treatment
A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.